MedTrace Logo

Post Market Clinical Follow-up of EUROSTEM Femoral Stem

NCT04995822 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 131

Last updated 2024-02-20

No results posted yet for this study

Summary

EUROSSTEM is intended for use in primary and revision total hip replacement surgery.

Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.

As part of post market vigilance, EUROS will collect data on EUROSTEM performances and safety

Conditions

  • Hip Osteoarthritis
  • Hip Arthropathy
  • Hip Arthritis
  • Hip Necrosis
  • Hip Fractures
  • Hip Dysplasia

Interventions

DEVICE

hip arthroplasty

Hip prosthesis surgery

Sponsors & Collaborators

  • EUROS

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-21
Primary Completion
2022-11-06
Completion
2032-11-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04995822 on ClinicalTrials.gov